Takeda Pharmaceutical Company Limited is currently undergoing a restructuring process, which raises questions about its standing in the Japanese stock market.
Investors are keen to assess whether Takeda can emerge as a top choice in the competitive pharmaceutical sector amidst these changes.
As the company navigates its restructuring, its future performance will be closely monitored by market analysts and investors alike.